Cue Biopharma to Host Business Update Call and Webcast

BOSTON, April 02, 2024 -- Cue Biopharma, Inc. , a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate disease-specific T cells,...

Related Keywords

Massachusetts , United States , Boston , Jonathan Pappas , Marie Campinell , Cue Biopharma Inc , International Investors , Corporate Communications , Nasdaq , Lifesci Communications , Linkedin , Ono Pharmaceutical , Selective Targeting , Markets ,